Core Description
UTMB has led the Comparative Effectiveness Research (CER) on Cancer in Texas (CERCIT) since 2010 under a multi-investigator award mechanism from the Cancer Prevention and Research Institute of Texas (CPRIT). Findings from CERCIT have been disseminated
via more than 187 publications spanning the cancer care continuum: screening (prevention and detection); diagnosis and treatment; post-treatment surveillance; and survivorship. Most importantly, CERCIT built the data infrastructure for cancer CER
through a close partnership with the Texas Cancer Registry (TCR) to link TCR data to Texas Medicare and Medicaid files. Another significant contribution in the first cycle of CERCIT was to train 27 junior clinical investigators in CER in the trajectory
of cancer care continuum through didactic experiences, and structured multidisciplinary mentoring in the Houston/Galveston area. In the current cycle, the training core focused on collecting patient reported outcomes, through a collaboration with
TCR.
With the above success, this state-wide Data Management and Analysis Core (DMAC) will 1) continue to build the data infrastructure, 2) expand to new data sources through linkage to national surveys to obtain patient-centered outcomes, and 3) train a new
cadre of investigators conducting cancer CER throughout the state, particularly those from Texas academic and research institutions with large numbers of under-represented investigators. We anticipate that, at the end of the 5 years of funding, we
will have mentored and trained a significant number of the next generation of cancer leaders who will determine the direction of cancer research in Texas.
The DMAC will become the hub for cancer CER in Texas.
News
Information: The Data Management and Analysis Core (DMAC) for Comparative Effectiveness Research (CER) on Cancer in Texas is looking for all investigators in Texas academic and research institutes who are interested in conducting CER on cancer to submit pilot grant proposals. Proposals from screening, diagnosis, treatment, post treatment surveillance, or survivorship are all welcome.
The DMAC jointly run by University of Texas Medical Branch - Galveston and University of Texas MD Anderson Cancer Center will provide mentorship on study design, data, and analysis supports. This is a great opportunity for investigators to develop
expertise on CER.
Please help us distribute this email and attached flyer to investigators at your institution. Applications are due Friday, May 26, 2023.
If you have questions, please reach out to Dr. David S. Lopez at davlopez@utmb.edu.
Download Flyer for DMAC Call Pilot